Above Food Delisted from Nasdaq, Commences Trading on OTC Market
Summary
Above Food Ingredients Inc. has been delisted from Nasdaq due to its failure to file audited financial statements and will now trade on the OTC market, with plans to appeal and seek re-listing.
Key Events · Legal and Risk Events · ABVE
-
Nasdaq Delisting Confirmed
Above Food Ingredients Inc. received a determination letter from the Nasdaq Hearings Panel to delist its common shares and warrants, effective June 2, 2026. The delisting is due to the company's failure to file its audited financial statements (Form 20-F) by the extended deadline, as per Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2).
-
Trading Moves to OTC Market
Following the delisting, the company's securities commenced trading on the Over-the-Counter (OTC) market on June 2, 2026, under the new trading symbol 'ABVEF' for common shares and 'ABVEWF' for warrants. This transition is expected to have a material adverse effect on trading price and volume.
-
Company Plans Appeal and Re-listing Efforts
Above Food Ingredients Inc. is considering an appeal to the Nasdaq Listing and Hearing Review Council and is working diligently to file its audited financial statements and meet all necessary re-listing requirements for Nasdaq.
Analysis · ABVE · Manufacturing
The delisting from Nasdaq to the Over-the-Counter (OTC) market is a severe blow to Above Food Ingredients Inc. This move significantly reduces the company's visibility, liquidity, and access to institutional capital, making it more challenging for investors to trade shares. The delisting stems from the company's failure to file its audited financial statements (Form 20-F) by the extended deadline, highlighting ongoing compliance and operational issues that have been previously disclosed. While the company intends to appeal and pursue re-listing, the immediate impact is highly negative for shareholders.
At the time of this filing, ABVE was trading at $0.07 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.8M. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.